Empiric, broad-spectrum antibiotic therapy with de-escalation for ventilator-associated pneumonia does not induce gram-negative pathogen resistance

被引:0
|
作者
Kopelman, Tammy R. [1 ]
O'Neill, Patrick J. [1 ]
Hibbard, Michael L. [1 ]
Matthews, Marc R. [1 ]
Cox, Jordy C. [1 ]
Quan, Asia N. [1 ]
Drachman, David A. [1 ]
机构
[1] Maricopa Cty Gen Hosp, Phoenix, AZ USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
836
引用
收藏
页码:A232 / A232
页数:1
相关论文
共 50 条
  • [41] Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
    Rattanaumpawan, Pinyo
    Lorsutthitham, Jintana
    Ungprasert, Puangpaka
    Angkasekwinai, Nasikarn
    Thamlikitkul, Visanu
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (12) : 2645 - 2649
  • [42] A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia IASIS Trial
    Kollef, Marin H.
    Ricard, Jean-Damien
    Roux, Damien
    Francois, Bruno
    Ischaki, Eleni
    Rozgonyi, Zsolt
    Boulain, Thierry
    Ivanyi, Zsolt
    Janos, Gal
    Garot, Denis
    Koura, Firas
    Zakynthinos, Epaminondas
    Dimopoulos, George
    Torres, Antonio
    Danker, Wayne
    Montgomery, A. Bruce
    CHEST, 2017, 151 (06) : 1239 - 1246
  • [43] Does broad-spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?
    Nordmann, Patrice
    Poirel, Laurent
    Toleman, Mark A.
    Walsh, Timothy R.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (04) : 689 - 692
  • [44] Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance
    D. E. Ghannam
    G. H. Rodriguez
    I. I. Raad
    A. Safdar
    European Journal of Clinical Microbiology & Infectious Diseases, 2009, 28 : 253 - 259
  • [45] Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance
    Ghannam, D. E.
    Rodriguez, G. H.
    Raad, I. I.
    Safdar, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2009, 28 (03) : 253 - 259
  • [46] Association Between Delayed Broad-Spectrum Gram-negative Antibiotics and Clinical Outcomes: How Much Does Getting It Right With Empiric Antibiotics Matter?
    Baghdadi, Jonathan D.
    Goodman, Katherine E.
    Magder, Laurence S.
    Claeys, Kimberly C.
    Sutherland, Mark E.
    Harris, Anthony D.
    CLINICAL INFECTIOUS DISEASES, 2025,
  • [47] Which trial do we need? Comparison of 7 versus 14 days of antibiotic therapy for ventilator-associated pneumonia due to highly resistant gram-negative bacteria
    Tleyjeh, Imad M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (09) : 1114 - 1116
  • [48] Effect of de-escalation antibiotic therapy on hospital-acquired, ventilator associated, and healthcare-associated pneumonia: A systematic review and meta-analysis
    Manabe, Toshie
    Fujikura, Yuji
    Teramoto, Shinji
    Hizawa, Nobuyuki
    Kudo, Koichiro
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [49] Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant Gram-negative bacteria
    Kollef, Katherhie E.
    Schramm, Garrett E.
    Wills, Angela R.
    Reichley, Richard M.
    Micek, Scott T.
    Kollef, Marin H.
    CHEST, 2008, 134 (02) : 281 - 287
  • [50] Rotation and restricted use of antibiotics in a medical intensive cave unit - Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria
    Gruson, D
    Hilbert, G
    Vargas, F
    Valentino, R
    Bebear, C
    Allery, A
    Bebear, C
    Gbikpi-Benissan, G
    Cardinaud, JP
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (03) : 837 - 843